Healthcare
Earth Science Tech CEO to Present at Planet MicroCap Las Vegas 2026 Conference
Earth Science Tech CEO Giorgio Saumat will present at the Planet MicroCap Las Vegas 2026 conference, highlighting the company's vertically integrated healthcare platform.
Austin Surgeon Expands Facial Services to Address GLP-1 Weight Loss Side Effects
Dr. Robert Whitfield MD launches no-cut facelift and Ozempic face treatment programs in Austin, responding to rising demand for non-surgical facial rejuvenation linked to rapid weight loss from GLP-1 medications.
Dr. Robert Whitfield Publishes Safety Research on Fat Transfer Breast Augmentation, Launches Comprehensive BII Health Program
Dr. Robert Whitfield's new BII Health Program pairs explant surgery with fat transfer and offers a non-surgical health optimization program based on the SHARP Method, integrating genetic testing, toxicity assessment, and personalized care.
Earth Science Tech Balances Healthcare Expansion with Aggressive Share Repurchases
Earth Science Tech Inc. (OTCPK: ETST) has repurchased 3.7 million shares over nine months, signaling a focus on shareholder value while expanding its telemedicine and pharmacy operations.
Quantum BioPharma Builds Diversified Pipeline Targeting Neurological and Wellness Markets
Quantum BioPharma Ltd. advances LUCID-MS for multiple sclerosis and expands into alcohol metabolism with unbuzzd, addressing unmet needs in neurology and wellness.
HeartBeam Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
A peer-reviewed study published in JACC: Advances demonstrates that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in patients with chest pain, potentially enabling earlier detection and treatment.
How to Get Affordable Dental Implants Without Sacrificing Quality
This guide explains the true costs of dental implants, factors influencing pricing, and strategies to save money while ensuring quality care.
Oncotelic Therapeutics Expands Sapu003 Phase 1b Program with Global CRO Appointment, Signaling Shift to Multinational Development
Oncotelic Therapeutics and Sapu Nano expand the Phase 1b trial for Sapu003, appointing Global Clinical Trials to lead international execution, marking a transition from an Australia-based study to a multinational strategy.
TransCode Therapeutics Reports Positive Phase 1a Results for TTX-MC138, Paving Way for Phase 2a Trial
TransCode Therapeutics announced positive Phase 1a results for its investigational microRNA-10b inhibitor TTX-MC138, showing durable disease stabilization and no dose-limiting toxicities, supporting advancement to Phase 2a clinical development.
Platform Biotech Models Attract Investor Attention as Drug-Delivery Market Nears $410 Billion
Biotechnology companies are increasingly focusing on platform technologies for drug delivery to maximize existing therapies, with the market projected to reach $410 billion, drawing investor interest to firms like Oncotelic Therapeutics.
New Pill Daraxonrasib Shows Promise in Doubling Survival for Pancreatic Cancer Patients
Revolution Medicines' daraxonrasib, targeting the KRAS gene, has reportedly doubled survival in early pancreatic cancer trials, offering cautious hope for a disease with limited treatment options.
Oncotelic Therapeutics Highlighted in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation
Oncotelic Therapeutics is featured in a BioMedWire editorial that examines how biotech companies use advanced drug-delivery technologies and AI platforms to enhance therapies, highlighting Oncotelic's Sapu003, Deciparticle, and PDAOAI initiatives.
VolitionRx Expands Patent Portfolio with Ebola Triage Application
VolitionRx has filed a patent for using its Nu.Q technology to triage and monitor potential Ebola patients, aiming to provide low-cost bedside testing in resource-limited outbreak zones.
Onco-Innovations Achieves Kilogram-Scale Manufacturing Milestone for Lead Cancer Drug Candidate
Onco-Innovations Limited successfully produced nearly a kilogram of the B4 precursor for its ONC010 PNKP inhibitor, advancing toward clinical trials and scalable production.
Lexaria Bioscience to Attend BIO International Convention Amid Record Business Development Interest
Lexaria Bioscience Corp. announces its attendance at the BIO International Convention in San Diego, highlighting a surge in partnership interest for its DehydraTECH drug delivery platform, which could lead to significant collaborations with pharmaceutical giants and biotech firms.
GeoVax CEO Sees Renewed Strategic Interest in Vaccine Platforms as Industry Shifts Toward Health Security
GeoVax Labs CEO David Dodd comments on recent pharmaceutical acquisitions, highlighting a strategic shift toward vaccine innovation and health security amid rising global infectious disease threats.
American Heart Association Launches First-Ever Heart Transplant Research Network to Address Innovation Gaps and Inequities
The American Heart Association's new research network, involving 14 centers and a coordinating center, aims to modernize heart transplant care by improving data infrastructure, advancing research, and standardizing quality care to address long-standing disparities and innovation gaps.
Wellness Index Report Reveals Consumer Shift from Longevity to Root-Cause Health and Human Potential
The Wellness Index Report highlights a major evolution in consumer wellness priorities toward understanding root causes and improving quality of life over simply extending lifespan.
Proposed HHS Rule Changes Could Reshape AI Regulation in Health Care, Sparking Debate on Innovation vs. Safety
The Department of Health and Human Services is considering easing AI health care safeguards, which could accelerate innovation but raise patient safety concerns.
How to Find Affordable Dental Implants Without Sacrificing Quality
This article explores strategies for obtaining affordable dental implants, emphasizing the importance of research, comparing clinics, and understanding pricing to achieve long-term value without compromising on quality.
Viromed Medical AG Completes Study on Cold Plasma Application in the Lung, Shows Promise for Treating Ventilator-Associated Pneumonia
Viromed Medical AG announces successful completion of a multi-year study on cold atmospheric plasma in the lung, demonstrating potential as a non-pharmacological treatment for severe infectious lung diseases, with first successful patient applications already achieved.
Quantum BioPharma Advances Multiple Sclerosis Drug Candidate Lucid-MS and Commercial Product unbuzzd™
Quantum BioPharma's lead drug Lucid-MS targets nerve damage in multiple sclerosis, with a Phase 2 trial upcoming, while its alcohol metabolism product unbuzzd™ generates royalty revenue.
AI-Powered Wearables Poised to Revolutionize Patient Monitoring and Clinical Decisions
Advances in AI and edge computing are transforming health care wearables from data collectors into tools for real-time clinical insights, benefiting companies like Apple and potentially easing burdens on health care systems.
Regentis Biomaterials Advances Simplified Cartilage Repair Platform Toward Key Milestones
Regentis Biomaterials is moving its cell-free hydrogel implant GelrinC toward U.S. market entry, targeting a $3 billion knee cartilage repair market with a simplified procedure that could replace traditional microfracture and cell-based therapies.
Heart Disease Risk Rising Among U.S. Women, New Report Warns
A new American Heart Association statement projects that by 2050, 6 in 10 U.S. women will have cardiovascular disease, driven by rising obesity, diabetes, and high blood pressure, but highlights prevention strategies to reverse the trend.
Regentis Biomaterials Targets $3 Billion U.S. Knee Cartilage Repair Market with Novel Off-the-Shelf Solution
Regentis Biomaterials' GelrinC platform offers a potential first-in-class, ready-to-use knee cartilage repair treatment with superior pain relief and faster recovery, advancing through U.S. Phase III trials.
Razi Orthodontics Expands Invisalign Services for Adults in Naperville, Offering Free Consultations
Razi Orthodontics now offers Invisalign for adults in Naperville, IL, with free consultations that lower barriers to treatment and emphasize clinical expertise over general dentistry.
Inhalable Viral Vector Shows Promise in Treating Advanced Lung Cancer
A new inhalable viral-based vector could enhance anti-cancer immune responses and restore sensitivity to immune checkpoint inhibitors in patients with advanced lung cancer.
New Orthodontic Practice Opens in Manhattan's Seaport District, Offering Invisalign and Braces
Seaport Orthodontics has opened in Manhattan's Seaport district, providing local access to Invisalign, braces, and early orthodontic treatment for residents who previously had to travel for specialized care.
Mia Orthodontics Opens Dedicated Orthodontic Practice in Houston's Upper Kirby
Mia Orthodontics has launched a specialty orthodontic practice in Houston's Upper Kirby neighborhood, offering board-certified care and personalized treatment plans for all ages.